Skip to main content
. 2023 Jan 9;9:1039464. doi: 10.3389/fmed.2022.1039464

TABLE 2.

Comparison of patients with and without a history of pneumococcal vaccination at baseline.

Variable Pneumococcal vaccine (−) Pneumococcal vaccine (+) P-value
n = 1,111 n = 586
Female, n (%) 885 (80.1%) 473 (81%) 0.66
Age, years, mean (SD) 60.4 (13.1) 64.0 (11.2) <0.001
Disease duration, years, mean (SD) 8.5 (8.5) 12.2 (8.9) <0.001
Early disease (<2 years), n (%) 249 (22.4%) 60 (10.2%) <0.001
RF and/or anti-CCP+, n (%) 518 (49.4%) 319 (56.5%) 0.007
Erosions, n (%) 306 (38.2%) 249 (57.2%) <0.001
Working, n (%) 343 (35.1%) 119 (21.4%) <0.001
Tertiary education, n (%) 173 (19.9%) 84 (16%) 0.06
DAS28-ESR, mean (SD) 3.46 (1.36) 3.29 (1.14) 0.015
HAQ, median (IQR) 0.25 (0.75) 0.25 (0.88) 0.39
Arthroplasties, n (%) 105 (9.5%) 66 (11.3%) 0.24
csDMARDs, n (%) 935 (84.2%) 476 (81.2%) 0.12
bDMARDs, n (%) 412 (37.1%) 347 (59.2%) <0.001
Glucocorticoids, n (%) 374 (33.7%) 222 (37.9%) 0.08
Glucocorticoids, mg/day, mean (SD) 5.2 (2.7) 4.5 (2.7) 0.002
Current smokers, n (%) 188 (18.1%) 92 (16.8%) 0.49
Alcohol use (>1 day/week) 62 (5.9%) 42 (7.6%) 0.20
Dyslipidemia, n (%) 341 (30.7%) 238 (40.6%) <0.001
Coronary artery disease, n (%) 46 (4.1%) 35 (6%) 0.09
Stroke, n (%) 31 (2.8%) 19 (3.2%) 0.60
Hypertension, n (%) 444 (40%) 280 (47.8%) 0.002
Diabetes, n (%) 147 (13.2%) 87 (14.8%) 0.36
COPD and/or RA-ILD, n (%) 62 (5.6%) 79 (13.5%) <0.001
Depression, n (%) 122 (11%) 84 (14.3%) 0.04
Osteoporosis, n (%) 267 (24%) 184 (31.4%) 0.001
Cancer (current/past), n (%) 72 (6.5%) 27 (4.6%) 0.12
History of hospitalization (last 12 months), n (%) 78 (7%) 54 (9.2%) 0.11
History of serious infection, n (%) 69 (6.2%) 89 (15.2%) <0.001
History of influenza vaccination, n (%) 347 (31.2%) 556 (94.9%) <0.001
BMI, kg/m2, mean (SD) 27.2 (5.1) 28.0 (5.4) 0.005
BMI > 30 kg/m2, n (%) 221 (19.9%) 164 (28%) <0.001
RDCI, median (IQR) 0 (1) 0 (1) 0.001